Followers | 256 |
Posts | 18838 |
Boards Moderated | 3 |
Alias Born | 12/02/2014 |
Wednesday, April 24, 2024 5:01:23 PM
ABQQ@ABIntlGroup
It is strange that all of our shareholder investors have had no reaction to the business progress we have updated here.
Reply
Travis@Travis77955789 Feb 13
The news is great but we have no reaction because we have no clue what percentage you are making off these movies and the swift era they seem to be making alot of money but what is $ABQQ getting ? If we knew this we would be excited and people would buy and the stock would go up
Well Deng stated in a Tweet
ABQQ@ABIntlGroup
~ 11% of the box office receipts
1:11 AM · Dec 10, 2023
1,298 Views
$ABQQ as per CEO distribution rights in China and for the Taylor Swift Eras Tour is 11% Revenue of All the Box office receipts in 7000-10,000 Screens throughout China, Worldwide every showing in every Country has been sold out making it the biggest cinematic tour in history pic.twitter.com/55aMQFg4hm
— www.TheTradingStockLounge.com (@ThePennyLounge) December 10, 2023
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174271717
Since this information was made in an email reply (link above) and not a public filling, I'll point out that if it takes 9 months to post this revenue it won't be on the books until Spring 2025 if they raise the $10m????
Reply: The $10.8m estimate revenue is based on an investment of $10m. Because the company still needs to raise US$10 million to participate in distribution investment in the Chinese film market, this quarter's revenue won’t to reflect related performance.
The box office settlement will take up to 9 months to complete, and the income of investment companies outside China must go through legal transfers to outside before they can be included in operating income.
All investments need to be implemented in accordance with regulations to receive income.
Recent ABQQ News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 08:05:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 08:04:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 06:08:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 05:57:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 07:45:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 05:12:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 04:33:38 PM
- US Airforce Contract Awarded to Epazz, Inc. (OTC Pink: EPAZ) • InvestorsHub NewsWire • 12/14/2023 11:48:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2023 04:35:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/01/2023 09:47:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:19:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/30/2023 08:55:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 08:35:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 04:24:58 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 05:57:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 03:53:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 09:24:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/13/2023 09:29:56 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM